Experimental Pathogenesis: Drugs and Chemical Lesions in the Gastric Mucosa

References

• Robbins SL, Cotran R S, Kumar V. Pathologic basis of disease4th ed. W.B. Saunders, Philadelphia 1984
   Google Scholar
• Guslandi M. Effect of ethanol on the gastric mucosa. Dig Dis 1987; 5: 21–32, suppl 1
   PubMedGoogle Scholar
• Szabo S. Mechanism of mucosal injury in the stomach and duodenum: Time-sequence analysis of morphologic, functional, biochemical and histo-chemical studies. Scand J Gastroenterol 1987; 22: 21–28, suppl 127
   Web of Science ®Google Scholar
• Schanker L S, Stone P A, Brodie B B, Hogben C, Adrian M. Absorption of drugs from the stomach in the rat. J Pharmacol Exp Ther 1957; 120: 528–539
   PubMed Web of Science ®Google Scholar
• Garda H A, Brenner R R. Short-chain aliphatic alcohols increase rat liver microsomal membrane fluidity and affect the activities of some microsomal membrane-bound enzymes. Biochim Biophys Acta 1984; 769: 160–170
   PubMedGoogle Scholar
• Boigegrain R A, Fernandez Y, Massol M, Mitjaila S. Thermodynamic interpretation of effects of alcohols on membrane lipid fluidity. Chem Phys Lipids 1984; 35: 321–330
   PubMedGoogle Scholar
• Kustarer K, Szabo S. Gastric mucosal protection by acetazolamine derivatives: role of carbonic anhy-drase and sulfhydryls. Eur J Pharmacol 1987; 141: 7–13
   PubMedGoogle Scholar
• Morris G P, Wallace J L, Harding PL. Effects of prostaglandin E2 on salicylate-induced damage to the rat gastric mucosa: cytoprotection is not associated with preservation of the gastric mucosal barrier. Can J Physiol Pharmacol 1984; 62: 1065–1069
   PubMedGoogle Scholar
• Tarnawski A, Hollander D, Stachura J, Krause W J, Gergely H. Prostaglandin protection of the gastric mucosa against alcohol injury–A dynamic time-related process. Gastroenterology 1985; 88: 334–352
   PubMed Web of Science ®Google Scholar
• Szabo S, Pihan G, Raza A, Muller E A, Hauschka PV. Multiple mechanisms of cell injury in the gastric mucosa. Fed Proc 1987; 48: 1152
   Google Scholar
• Szabo S, Trier J S, Frankel PW. Sulfhydryl compounds may mediate gastric cytoprotection. Science 1981; 214: 200–202
   PubMed Web of Science ®Google Scholar
• Szabo S, Trier J S, Brown A, Schnoor J., Jr. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 1985; 88: 228–236
   PubMed Web of Science ®Google Scholar
• Leung F W, Robert A, Guth PH. Gastric mucosal blood flow in rats after administration of 16,16-dimethyl prostaglandin E2 at a cytoprotective dose. Gastroenterology 1985; 88: 1948–1983
   PubMed Web of Science ®Google Scholar
• Roth SH. Nonsteroidal anti-inflammatory drug gastropathy. Arch Intern Med 1986; 146: 1075–1076
   PubMedGoogle Scholar
• Szabo S, Spill W F, Rainsford KD. Non-steroidal anti-inflammatory drug-induced gastropathy: mechanisms and management. Med Toxicol Adv Drug Exp 1989; 4: 77–94
   PubMedGoogle Scholar
• Domschke S, Domschke W. Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 1984; 13: 405–436
   PubMedGoogle Scholar
• Abramson S B, Weissman G. The mechanisms of action of nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1989; 32: 1–9
   PubMed Web of Science ®Google Scholar
• Kauffman G L, Awes D, Grossman MI. Intravenous indomethacin and aspirin reduce basal gastric mucosal blood flow in dogs. Am J Physiol 1980; 238: G131–G134
   Google Scholar
• Rainsford KD. The effects of aspirin and other nonsteroidal anti-inflammatory/analgesic drugs on the gastrointestinal mucous glycoprotein biosynthesis in vivo: relationship to ulcerogenic actions. Biochem Pharmacol 1978; 27: 877
   PubMed Web of Science ®Google Scholar
• Bagshaw P F, Munster D J, Wilson JW. Molecular weight of gastric mucus glycoprotein is a determinant of the degree of subsequent aspirin induced chronic gastric ulceration in the rat. Gut 1987; 28: 287–293
   PubMedGoogle Scholar
• Adams SS. Non-steroidal anti-inflammatory drugs, plasma half-lives, and adverse reactions. Lancet 1989; 2: 1204–1205
   Google Scholar
• Laska E M, Sunshine A, Marrero I, Olson N, Siegel C, McCormick N. The correlation between blood levels of ibuprofen and clinical analgesic response. Clin Pharmacol Ther 1986; 40: 1–7
   PubMed Web of Science ®Google Scholar
• Robert A, Nezemis J E, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats: prevention of gastric necrosis produced by alcohol, HCI, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979; 77: 433–443
   PubMed Web of Science ®Google Scholar
• Miller TA. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 1983; 234: G601–G603
   Google Scholar
• Mozsik G Y, Moron F, Fiegler M. Prostaglandins Leucotrienes Med 1983; 12: 423–436
   PubMedGoogle Scholar
• Szabo S, Gallagher G T, Horner H C, et al. Role of adrenal cortex in gastric mucosal protection by prostaglandins, sulfhydryls and cimitidine in the rat. Gastroenterology 1983; 85: 493–497
   Google Scholar
• Pihan G, Rogers C, Szabo S. Vascular injury in acute gastric mucosal damage. Mediatory role of leukotrienes. Dig Dis Sci 1983; 33: 625–632
   Google Scholar
• Peskar B M, Lange K, Hoppe U, Peskar BA. Etha-nol stimulates formation of leukotriene C4 in rat gastric mucosa. Prostaglandins 1986; 31: 283–292
   PubMed Web of Science ®Google Scholar
• Morales R E, Johnson B R, Szabo S. Endothelin induces hemorrhagic gastric mucosal lesions and aggravates the damaging effect of HCI and ethanol. Dig Dis Sci 1989; 34: 1318
   Google Scholar
• Whittle B, JR. Endothelin, an endogenous vascular peptide induces injury to the rat gastric mucosa. Gastroenterology 1986; 96: A544
   Google Scholar
• Dupuy D, Kronauge J F, Jones A G, Szabo S. Gastric mucosal protection may be mediated through increases in vascular permeability which create a histodilutional barrier. Gastroenterology 1988; 94: A615
   Web of Science ®Google Scholar
• Palitzsch KD, Morales RE, Kronauge JF, Szabo S. Biphasic effect of histamine on hemorrhagic mucosal lesions is related to vascular permeability: studies with histamine, HI-, H2- and H3-antagonists and bradykinin. Gastroenterology 1989; 96: A381
   Google Scholar